Congruence Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6666 Saint-urbain St Ste 450, Montreal, ...Phone Number
(438) 817-3666Website
www.congruencetx.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Congruence Therapeutics
Founded and based in Canada, Congruence Therapeutics is a drug discovery company harnessing the power of innovative fields such as protein dynamics, biophysics, machine learning and computational chemistry with focus on rare disease treatment.Explore more
Congruence Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
MH
Chief Development Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Congruence Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Congruence Therapeutics
Funding: Get notified immidiatlly once Congruence Therapeutics has new funding data
Click to see if Congruence Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Congruence Therapeutics recently announced quarterly report
Product Launch: Get notified when Congruence Therapeutics launches new products
Congruence Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Congruence Therapeutics is spiking on competitors!
Check if Congruence Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Congruence Therapeutics
Compare insights from companies similar to Congruence Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Congruence Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Congruence Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Congruence Therapeutics.
Congruence Therapeutics financials insights
Gather financial insights about Congruence Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$65M
2025
Other Financing Round
$32M
2026
Other Financing Round
$39.5M
Congruence Therapeutics Tech Stack
A closer look at the technologies used by Congruence Therapeutics
Most Recent Scoops
Funding
Funding
Funding
Funding
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Congruence Therapeutics News & Media
Congruence Therapeutics to Present Preclinical Characterization of its MC4R Corrector Development Candidate CGX-926 for Genetic Obesity at ObesityWeek 2025
– Presentation highlights in vitro activity across a spectrum of clinically-relevant variants as well as in vivo reduction of body weight and hyperphagia in MC4R-deficient Mutant Mice – MONTREAL, Nov. 6, 2025 /PRNewswire/ -- Congruence Therapeutics, a computationally-driven biotechnology...Congruence Therapeutics Earns "Fierce 15" Distinction for 2025
MONTREAL, Sept. 22, 2025 /PRNewswire/ -- Congruence Therapeutics, a computationally-driven biotechnology company building a unique pipeline of pharmacological correctors for diseases of protein misfolding, today announced that Fierce Biotech has named it as one of 2025's Fierce 15...Congruence Therapeutics Announces Oral Presentation on Novel GCase Activators and Correctors for Parkinson's Disease with GBA1 Mutations at the GBA1 Meeting 2025
-Congruence is optimizing several GCase-targeting compounds for GBA-1 Parkinson's disease- MONTREAL, June 3, 2025 /PRNewswire/ -- Congruence Therapeutics, a computationally-driven biotechnology company building a unique pipeline of correctors for diseases of protein misfolding, including...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Congruence Therapeutics
Sign Up For FreeTo access detailed company insights
Founded and based in Canada, Congruence Therapeutics is a drug discovery company harnessing the power of innovative fields such as protein dynamics, biophysics, machine learning and computational chemistry with focus on rare disease treatment.... Read More
